https://www.worldpharmatoday.com/research-insight/eisai-and-uclommence-preparations-for-phase-i-clinical-studies-in-alzheimer-s-disease-for-novel-anti-tau-antibody/ Magazine for the C-level Pharma Executives Mon, 10 Dec 2018 06:53:08 +0000 hourly 1 https://wordpress.org/?v=6.9.4